Allosteric Modulation of the CB1 Receptor

CB1 受体的变构调节

基本信息

  • 批准号:
    10592492
  • 负责人:
  • 金额:
    $ 68.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

Abstract Alcohol use disorder (AUD) represents a significant burden on human health and society. Existing medications to treat AUD (acamprosate, disulfiram, and naltrexone) have modest efficacy and thus there is continued emphasis on developing novel and effective drugs. The cannabinoid type-1 (CB1) receptor represents a promising AUD treatment target with a clearly demonstrated role in modulating many alcohol-related behaviors and having contributions to the motivational and reinforcing properties of ethanol. The CB1 antagonist/inverse agonist rimonabant effectively reduces alcohol consumption/self-administration, withdrawal severity, and cue- induced relapse. Unfortunately, rimonabant was withdrawn in Europe after its initial approval for obesity treatment because of untoward side effects in humans including anxiety and depression, and development of other CB1 antagonists/inverse agonists has also been halted. As an alternative strategy, our team has synthesized and characterized a library of CB1 receptor negative allosteric modulators (NAMs), ligands that bind to a distinct site than the orthosteric site(s) and modulate the effects of the orthosteric ligands. CB1 NAMs have been shown to effectively block agonist signaling in multiple in vitro assays, similar to rimonabant. Our studies demonstrated that RTICBM-74, a CB1 NAM developed by our team, dose-dependently reduced alcohol consumption without affecting sucrose intake in rats. Importantly, RTICBM-74 showed no anxiety-like behavior at the same dose in an elevated plus maze (EPM) and an open field, whereas rimonabant displayed anxiety-like behavior with decreased time in the open arm in EPM. The goal of this proposal is to further optimize these promising CB1 NAMs to improve the overall properties, particularly increasing solubility and decreasing lipophilicity (Aims 1-2), and evaluate their effects on alcohol self-administration, relapse-like behavior, anxiety- related behavior and anhedonia in rats (Aim 3). Together, these studies have the potential to identify novel CB1 NAMs as a possible therapeutic strategy for the treatment of AUD.
摘要 酒精使用障碍(AUD)是人类健康和社会的重大负担。现有 治疗AUD的药物(阿坎酸、双硫仑和纳曲酮)具有适度的功效,因此存在 继续重视开发新的和有效的药物。大麻素1型(CB 1)受体代表 一个有前途的AUD治疗靶点,在调节许多酒精相关行为中具有明确的作用 并对乙醇的激励和增强性能做出贡献。CB 1拮抗剂/反向 激动剂利莫那班有效地减少酒精消耗/自我管理,戒断严重程度和线索, 诱导复发。不幸的是,利莫那班在最初批准用于治疗肥胖后,在欧洲被撤回 治疗,因为人类的不良副作用,包括焦虑和抑郁,以及发展, 其它CB 1拮抗剂/反向激动剂也已停止。作为替代策略,我们的团队 合成并表征了CB 1受体负变构调节剂(NAMs)库, 与正构位点不同的位点,并调节正构配体的作用。CB 1 NAM具有 在多个体外试验中显示有效阻断激动剂信号传导,类似于利莫那班。我们的研究 证明RTICBM-74,一种由我们团队开发的CB 1 NAM, 消耗而不影响大鼠的蔗糖摄入量。重要的是,RTICBM-74没有表现出焦虑样行为 在高架十字迷宫(EFL)和开放视野中, 行为与减少时间的开放臂在pneumatic。该提案的目标是进一步优化这些 有希望的CB 1 NAM改善整体性能,特别是增加溶解度和降低溶解度。 亲脂性(目的1-2),并评估其对酒精自我管理,复发样行为,焦虑, 大鼠相关行为和快感缺失(目的3)。总之,这些研究有可能发现新的CB 1 NAM作为治疗AUD的可能治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOYCE BESHEER其他文献

JOYCE BESHEER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOYCE BESHEER', 18)}}的其他基金

The role of peripheral cardiovascular signals in the interoceptive effects of alcohol
外周心血管信号在酒精内感受作用中的作用
  • 批准号:
    10592619
  • 财政年份:
    2023
  • 资助金额:
    $ 68.19万
  • 项目类别:
2024 Alcohol and the Nervous System Gordon Research Conference and Gordon Research Seminar
2024酒精与神经系统戈登研究会议暨戈登研究研讨会
  • 批准号:
    10827607
  • 财政年份:
    2023
  • 资助金额:
    $ 68.19万
  • 项目类别:
Small molecule antagonist probes for the relaxin-3/RXFP3 system
松弛素 3/RXFP3 系统的小分子拮抗剂探针
  • 批准号:
    10266756
  • 财政年份:
    2020
  • 资助金额:
    $ 68.19万
  • 项目类别:
Small molecule antagonist probes for the relaxin-3/RXFP3 system
松弛素 3/RXFP3 系统的小分子拮抗剂探针
  • 批准号:
    10410553
  • 财政年份:
    2020
  • 资助金额:
    $ 68.19万
  • 项目类别:
Consequences of prenatal alcohol and cannabinoid co-exposure on alcohol self-administration in adolescence
产前酒精和大麻素共同暴露对青春期自我饮酒的影响
  • 批准号:
    9763396
  • 财政年份:
    2018
  • 资助金额:
    $ 68.19万
  • 项目类别:
Gene Delivery of Neuroactive Steroids to Modulate Ethanol Reinforcement/Consumption
神经活性类固醇的基因传递以调节乙醇强化/消耗
  • 批准号:
    9237639
  • 财政年份:
    2017
  • 资助金额:
    $ 68.19万
  • 项目类别:
Gene Delivery of Neuroactive Steroids to Modulate Ethanol Reinforcement/Consumption
神经活性类固醇的基因传递以调节乙醇强化/消耗
  • 批准号:
    9894698
  • 财政年份:
    2017
  • 资助金额:
    $ 68.19万
  • 项目类别:
Characterization of alcohol self-administration following predator odor exposure: relevance to PTSD
暴露于捕食者气味后自我饮酒的特征:与 PTSD 的相关性
  • 批准号:
    9976414
  • 财政年份:
    2017
  • 资助金额:
    $ 68.19万
  • 项目类别:
Characterization of alcohol interoceptive effects following predator odor exposure: relevance to PTSD
捕食者气味暴露后酒精内感受效应的表征:与 PTSD 的相关性
  • 批准号:
    10665399
  • 财政年份:
    2017
  • 资助金额:
    $ 68.19万
  • 项目类别:
Characterization of alcohol self-administration following predator odor exposure: relevance to PTSD
暴露于捕食者气味后自我饮酒的特征:与 PTSD 的相关性
  • 批准号:
    9485726
  • 财政年份:
    2017
  • 资助金额:
    $ 68.19万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 68.19万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了